CCRB Logo

Trial History Detail on 2009-11-27

CUHK_CCT00060

2005-09-09

Retrospective

n/a

RGC Grant

n/a

n/a

Benny Fok

Department of Medicine and Therapeutics

26323377

bfok@cuhk.edu.hk

The Chinese University of Hong Kong

Kenneth KC Lee

School of Pharmacy

26096827

kclee@cuhk.edu.hk

The Chinese University of Hong Kong

The effect of Orlistat and Rosiglitazone on insulin action in a grouop of Chinese patients affected by the metabolic syndrome -- a randomized, single-blinded and placebo controlled study

The effect of Orlistat and Rosiglitazone on insulin action in a grouop of Chinese patients affected by the metabolic syndrome -- a randomized, single-blinded and placebo controlled study

n/a

Hong Kong

Yes

1999-09-08

Gland and Hormone Related Diseases

Drug

Orlistat

1 year

Rosiglitazone

Patients with impaired glucose tolerance or type 2 diabetes

Patients on insulin or requiring more than one diabetic medication

18

75

Both Male and Female

Interventional

Randomized

Active

Single-blind

Parallel

2001-07-01

75

Complete

insulin action in patients with impaired glucose tolerance or type 2 diabetes

changes in cardiovascular risk factors

No

2009-11-27


Yes

Type Access Document Published On  
No documents yet.
  • Page 1 of 1.